Bristol-Myers Squibb Company (bmy)
BMY Estimates
Analyst price targets and consensus estimates for Bristol-Myers Squibb Company are not published on this public page.
Analyst estimates & price targets is available in Vest Terminal for Professional and Enterprise subscribers.
Bristol-Myers Squibb Company FAQ
What does Bristol-Myers Squibb Company (BMY) do?
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovascular, and neuroscience indications. Its products include Op…
What is BMY's P/E ratio?
Bristol-Myers Squibb Company has a trailing P/E of 14.04× based on publicly available market data.
Does BMY pay a dividend?
Indicated dividend yield: 4.0%. Confirm ex-dates and payout history in Vest Terminal.
What sector is BMY in?
Bristol-Myers Squibb Company is classified in Healthcare (Drug Manufacturers - General) on NYQ.
What is BMY's market capitalization?
Approximate market cap: $131.04B.
What are the main risks for BMY?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of BMY?
Potential positives include revenue growth of 5.7% year-over-year, earnings growth of 1.5% year-over-year.
Where can I get analyst estimates for BMY?
Consensus estimates, price targets, and detailed analyst data for Bristol-Myers Squibb Company are available to Professional subscribers in Vest Terminal — not on this public summary page.